Identification of a novel recycling sequence in the C-tail of FPR2/ALX receptor: association with cell protection from apoptosis.
36166 - 36178
J Biol Chem
MetadataShow full item record
Formyl-peptide receptor type 2 (FPR2; also called ALX because it is the receptor for lipoxin A4) sustains a variety of biological responses relevant to the development and control of inflammation, yet the cellular regulation of this G-protein-coupled receptor remains unexplored. Here we report that, in response to peptide agonist activation, FPR2/ALX undergoes β-arrestin-mediated endocytosis followed by rapid recycling to the plasma membrane. We identify a transplantable recycling sequence that is both necessary and sufficient for efficient receptor recycling. Furthermore, removal of this C-terminal recycling sequence alters the endocytic fate of FPR2/ALX and evokes pro-apoptotic effects in response to agonist activation. This study demonstrates the importance of endocytic recycling in the anti-apoptotic properties of FPR2/ALX and identifies the molecular determinant required for modulation of this process fundamental for the control of inflammation.
AuthorsThompson, D; McArthur, S; Hislop, JN; Flower, RJ; Perretti, M
- Inflammation 
Showing items related by title, author, creator and subject.
Pallett, LJ; Davies, J; Colbeck, EJ; Robertson, F; Hansi, N; Easom, NJW; Burton, AR; Stegmann, KA; Schurich, A; Swadling, L;... (Rockefeller University Press, 2017-05-19)The liver provides a tolerogenic immune niche exploited by several highly prevalent pathogens as well as by primary and metastatic tumors. We have sampled healthy and hepatitis B virus (HBV)-infected human livers to probe ...
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research SANGER, GJ; Andrews, PLR (Frontiers Media, 2018-09-04)The origins of the major classes of current anti-emetics are examined. Serendipity is a recurrent theme in discovery of their anti-emetic properties and repurposing from one indication to another is a continuing trend. ...
Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation. McArthur, S; Gobbetti, T; Kusters, DH; Reutelingsperger, CP; Flower, RJ; Perretti, M (2015-08-01)Blood-derived monocytes remove apoptotic cells and terminate inflammation in settings as diverse as atherosclerosis and Alzheimer's disease. They express high levels of the proresolving receptor ALX/FPR2, which is activated ...